NSE filing, NSE: STARHEALTH. Summary written from the filing by ALFA Finder's alert engine.
Star Health and Allied Insurance Company Ltd: key numbers
- Share price
- ₹530.50
- Market cap
- ₹31,176 Cr
- Revenue (annual)
- ₹17,825 Cr
- Net profit (annual)
- ₹557.0 Cr
- P/E (TTM)
- 29.6×Sector 19.5×
- Promoter holding
- 58.00%-0.01% QoQ
- FII holding
- 15.86%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Star Health and Allied Insurance Company Ltd
All →Star Health and Allied Insurance Company Results Update
Star Health reported Normalised PAT of ₹390 Crores in Q2 FY27, up 70% YoY. H1 FY27 PAT stood at ₹815 Crores, up 57% YoY.
Star Health and Allied Insurance Company Earnings Call Transcript: Key Takeaways
Star Health reported a significant structural turnaround with underwriting profitability for the fifth consecutive quarter.
- Call
- Guides 20% growth
Star Health and Allied Insurance Company Other Announcement
Star Health filed a NIL Reg 54 security cover certificate for unsecured NCDs. No secured debt is covered, so this is routine compliance.
Star Health and Allied Insurance Company Investor Presentation: Key Takeaways
H1 FY27 PAT ₹815 Cr (+57%); CISR improved to 97.9% from 100.3%; underwriting result ₹210 Cr vs loss ₹24 Cr. Retail fresh GWP +36%, driven by agency and D2C. Reported profit includes ₹229 Cr MTM gain.
Star Health and Allied Insurance Company Promoter Reclassification
Star Health's board approved reclassifying Sthitaprajna Advisors LLP from promoter group to public shareholder category. The move is subject to requisite regulatory approvals.
Star Health and Allied Insurance Company Q2 FY27 Results: Net Profit ₹264.8 Cr, Up 232.7% YoY
Star Health and Allied Insurance Company Ltd reported revenue from operations of ₹5,074 Cr (+15.4% YoY) and net profit of ₹264.8 Cr (+232.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹264.8 Cr · +232.7% YoY
Other price movement clarification announcements
All →Abram Food Price Movement Clarification
Abram Food Limited clarified that recent equity share price movements are purely market-driven. The company confirmed there is no undisclosed price-sensitive information or pending announcements.
Dhillon Freight Carrier Price Movement Clarification
Dhillon Freight Carrier Ltd clarified that recent share price movements are market-driven. The company confirmed no undisclosed material events or information exist that could affect its scrip behavior.
Innovision Price Movement Clarification
Innovision Ltd clarified that recent equity share price movements are market-driven with no undisclosed material information. The company confirmed full compliance with SEBI disclosure regulations.
Aegis Logistics Price Movement Clarification
Aegis Logistics clarified to BSE that the unusual volume surge is purely market-driven with no undisclosed information. The company confirmed compliance with Reg 30 LODR.
Marsons Price Movement Clarification
Marsons Ltd. replied to an exchange price-movement query stating no undisclosed information exists. The company affirmed compliance with LODR and no future disclosure is pending.
Dr. Reddy's Laboratories Price Movement Clarification
Dr. Reddy's confirms FDA tentative approval for its lenacapavir HIV shot. The company states the news is not material and has no material impact.